Skip to content

Effect of Fasting and Refeeding on T-cell Fate

Pilot Study to Evaluate the Effect of Fasting and Refeeding on T-Cell Fate

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02719899
Enrollment
28
Registered
2016-03-25
Start date
2016-04-18
Completion date
2017-02-24
Last updated
2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Inflammation

Keywords

NLRP3 Inflammasome, Sirtuin 3, T-Cell Polarity, Caloric Restriction, Natural History

Brief summary

Background: Researchers want to better understand the body s immune response to calorie restriction. To do this, they are asking healthy volunteers to fast for 24 hours. Researchers will test immune response before and after fasting. Objectives: To explore the benefits of calorie restriction on immune health. Eligibility: Healthy volunteers ages 21 to 37 with a body mass index between 22 and 29. Design: Participants will be screened with medical history, physical exam, and blood tests. Participants will visit NIH after an overnight fast. Their baseline immune response will be taken. They will give blood and urine samples. Then they will be given breakfast. This visit will take about 2 hours. Participants will fast (not eat or drink anything except water) for the next 24 hours. They will return to NIH the next morning. Their immune response will be taken. They will give blood and urine samples. Then they will be given breakfast. Their immune response will be taken 3 hours later. They will give a blood sample. This visit will take about 4 hours.

Detailed description

Intermittent caloric restricted or fasting has numerous health effects including the reduction in numerous cardiovascular and pulmonary disease risk factors. The cellular programs activated by caloric restriction are similarly regulated in preclinical and clinical studies in response to a 24-hour fast. We have found that a beneficial effect of a 24-hour fasting blunts the activation of a component of the innate immune system, termed the NLRP3 inflammasome. This inflammasome, as a mediator of sterile inflammation, is associated with the development of diabetes, asthma and atherosclerosis. At the same time, we found that refeeding after the 24-hour fast significantly increased NLRP3 protein levels. As NLRP3 is increased in obesity, the nutrient intervention (24 hour fast and then refeeding) we studied may be useful to evaluate nutrient-overload effects on the immune system. Pertaining to this it has recently been found in a preclinical study that NLRP3 can also orchestrate differentiation of na(SqrRoot) ve T cells into T(H)2 cells. Interestingly both the NLRP3 inflammasome and T(H)2 cell activation contribute to asthma. In this context we hypothesize that the assessment of the effect on refeeding on T(H)2 cell differentiation (polarity) may allow us to dissect out the mechanisms underpinning nutrient overload induced T(H)2 cell activation. To evaluate this blood samples to test T-cell biology will be collected in subjects, at baseline, after a fixed caloric meal and in response to a 24-hour fast (water intake will not be restricted). The objective of this pilot study is to identify if nutrient-load regulates T-Cell differentiation capacity and to test whether this pathway could be investigated as a therapeutic target to blunt/negate the inflammation associated with nutrient-excess associated diseases including asthma.

Interventions

None listed

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
Lead SponsorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 37 Years
Healthy volunteers
No

Inclusion criteria

* INCLUSION CRITERIA: As this is a pilot study, the age-range and BMI range of subjects will be restricted to potentially reduce metabolic variables associated with a wide age- and BMI-range. * Males and females between the ages of 21 and 37 * BMI greater than or equal to 22 and less than 30

Exclusion criteria

* Subjects with an acute or chronic illness as per history, on laboratory analysis or due to use of medications * Subjects taking vitamins or supplements or any medications, except oral contraceptives, within 4 weeks of participation into this study * BMI less than 22 or greater than or equal to 30 * Female subjects who are pregnant or lactating * Subjects who have donated blood or participated in another clinical trial involving blood draws in the last 8 weeks * Subjects who use nicotine products

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome will be the change in TH2 cell cytokine (IL-4, IL-5 and/or IL-13) secretion in response to T-cell differentiation comparing the fasted to the refeeding response.24 hoursThe comparisons will be performed using paired two-tailed Student t-tests. Significance will be tested at the 0.05 alpha level in this pilot study

Secondary

MeasureTime frameDescription
To identify if nutrient-load regulates T-Cell differentiation capacity and to test whether this pathway could be investigated as atherapeutic target to blunt/negate the inflammation associated with nutrient-excess associated diseases includin...Visit 3, 3hrs post-mealBlood samples to test T-cell biology will be collected in subjects, at baseline, after a fixed caloric meal and in response to a 24-hour fast (water intake will not be restricted). Analysis of T-cell interleukin expression and regulation and mitochondrial functioning in primary T-cells. Analysis of mitochondrial biology in these immune-modulatory effects.
Evaluate whether these effects are associated with activation of the Sirt3 and its canonical mitochondrial adaptive programs.Visit 3, 3hrs post-mealAnalysis of difference in additional T-cell polarity signatures. Analysis ofcytokine and other protein levels in serum comparing the fed versus fasted states. Analysis of serum metabolites that may be modulating T-cell polarity.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026